FDA - Intent to Sole Source Molecular Operating Environment

Closed Solicitation Posted

Solicitation number
7571TE26Q00038
Agency
Not on record
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
513210 Software Publishers
Place of performance
Silver Spring, Maryland 20993, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Food and Drug Administration intends to award a sole source contract to Chemical Computing Group ULC for the Molecular Operating Environment (MOE), a cheminformatics and molecular modeling software platform, with notice posted June 9 and objection deadline June 16.

The procurement is justified under FAR 6.103-1 on the grounds that only Chemical Computing Group ULC is capable of providing the specialized molecular modeling software package required to support the Division of Applied Regulatory Science's analytical capabilities. MOE enables three-dimensional structural analysis and representation essential for evaluating adverse drug reactions that cannot be adequately assessed through two-dimensional methods alone. The vendor is the sole source capable of delivering customizable molecular docking models, computational models updating chemical descriptors, chemical database management support, and modeling of diverse molecule types and molecular interactions including organic, metallic, and biomolecules.

Place of performance is Silver Spring, Maryland. The period of performance runs from June 29, 2026 to June 28, 2027 (base year), with four one-year option periods extending through June 28, 2031. The NAICS code is 513210, Software Publishers; the PSC code is 7A20, IT and Telecom — Application Development Software (Perpetual License Software). Potential sources other than Chemical Computing Group ULC may submit a capability statement to Carlton Taylor via email to provide grounds for reconsideration before award.

Notice text

                                                                  NOTICE OF INTENT TO SOLE SOURCE

The U.S. Food and Drug Administration intends to award a sole source contract to Chemical Computing Group ULC to enhance the Division of Applied Regulatory Science (DARS) analytical capabilities beyond traditional two-dimensional (2D) methods. The Molecular Operating Environment (MOE), a comprehensive cheminformatics and molecular modeling software platform enables three-dimensional (3D) structural analysis and representation, which has proven essential for conducting more robust evaluations of adverse drug reactions that cannot be adequately assessed through 2D approaches alone.

The anticipated period of performance will consist of a base year, plus four one-year option periods.

Base Period :                       06/29/2026 to 06/28/2027

Option Period One:             06/29/2027 to 06/28/2028

Option Period Two:             06/29/2028 to 06/28/2029

Option Period Three:          06/29/2029 to 06/28/2030

Option Period Four:             06/29/2030 to 06/28/2031

The award will be a single source procurement awarded to Chemical Computing Group ULC, in accordance with RFO-FAR 6.103-1 Only one responsible source and no other supplies or services will satisfy agency requirements. Contracting Officers may solicit from only one source if the circumstances of the contract action deem that only one source is reasonably available based on licensing agreements and warranty coverage on specialized equipment.

Only one source, Chemical Computing Group ULC, is capable of fulfilling the Government’s requirement to provide the molecular modeling software package to communicate and provide customizable molecular docking models, computational models updating chemical descriptors, support chemical database management, and provide modeling diverse types of molecules and molecular interactions (organic, metallic, biomolecules).

This notice is not a solicitation or a request for offers. Any potential sources other than Chemical Computing Group ULC may submit a capability statement via email to Carlton Taylor, at carlton.taylor@hhs.gov by 12:00 PM EST on Tuesday June 16, 2026.

Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Oral communications are not acceptable in response to this notice.

A determination by the Government not to compete the proposed procurement based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. A solicitation will not be issued.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to Sole Source NAICS 334516 — No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity